Abstract P4-08-28: Clinical risk prediction models for breast cancer: A review of models developed between 2010 and 2018

2019 ◽  
Author(s):  
S Siesling ◽  
T Hueting ◽  
B Tip ◽  
R Mentink ◽  
E Koffijberg
Keyword(s):  
Breast Cancer ◽  
Risk Prediction ◽  
Prediction Models ◽  
Risk Prediction Models ◽  
Clinical Risk

Performance Metrics for the Comparative Analysis of Clinical Risk Prediction Models Employing Machine Learning

2021 ◽  
Author(s):  
Chenxi Huang ◽  
Shu-Xia Li ◽  
César Caraballo ◽  
Frederick A. Masoudi ◽  
John S. Rumsfeld ◽  
...  
Keyword(s):  
Machine Learning ◽  
Risk Prediction ◽  
Health Care Professionals ◽  
Clinical Decision Making ◽  
Performance Metrics ◽  
Prediction Models ◽  
Learning Models ◽  
Risk Prediction Models ◽  
Clinical Risk ◽  
Machine Learning Models

Background: New methods such as machine learning techniques have been increasingly used to enhance the performance of risk predictions for clinical decision-making. However, commonly reported performance metrics may not be sufficient to capture the advantages of these newly proposed models for their adoption by health care professionals to improve care. Machine learning models often improve risk estimation for certain subpopulations that may be missed by these metrics. Methods and Results: This article addresses the limitations of commonly reported metrics for performance comparison and proposes additional metrics. Our discussions cover metrics related to overall performance, discrimination, calibration, resolution, reclassification, and model implementation. Models for predicting acute kidney injury after percutaneous coronary intervention are used to illustrate the use of these metrics. Conclusions: We demonstrate that commonly reported metrics may not have sufficient sensitivity to identify improvement of machine learning models and propose the use of a comprehensive list of performance metrics for reporting and comparing clinical risk prediction models.

A Validated Risk Prediction Model for Breast Cancer in US Black Women

2021 ◽  
Author(s):  
Julie R. Palmer ◽  
Gary Zirpoli ◽  
Kimberly A. Bertrand ◽  
Tracy Battaglia ◽  
Leslie Bernstein ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Estrogen Receptor ◽  
Black Women ◽  
Prediction Model ◽  
Risk Prediction ◽  
Prediction Models ◽  
Risk Prediction Model ◽  
Risk Prediction Models ◽  
Relative Risks ◽  
Discriminatory Accuracy

PURPOSE Breast cancer risk prediction models are used to identify high-risk women for early detection, targeted interventions, and enrollment into prevention trials. We sought to develop and evaluate a risk prediction model for breast cancer in US Black women, suitable for use in primary care settings. METHODS Breast cancer relative risks and attributable risks were estimated using data from Black women in three US population-based case-control studies (3,468 breast cancer cases; 3,578 controls age 30-69 years) and combined with SEER age- and race-specific incidence rates, with incorporation of competing mortality, to develop an absolute risk model. The model was validated in prospective data among 51,798 participants of the Black Women's Health Study, including 1,515 who developed invasive breast cancer. A second risk prediction model was developed on the basis of estrogen receptor (ER)–specific relative risks and attributable risks. Model performance was assessed by calibration (expected/observed cases) and discriminatory accuracy (C-statistic). RESULTS The expected/observed ratio was 1.01 (95% CI, 0.95 to 1.07). Age-adjusted C-statistics were 0.58 (95% CI, 0.56 to 0.59) overall and 0.63 (95% CI, 0.58 to 0.68) among women younger than 40 years. These measures were almost identical in the model based on estrogen receptor–specific relative risks and attributable risks. CONCLUSION Discriminatory accuracy of the new model was similar to that of the most frequently used questionnaire-based breast cancer risk prediction models in White women, suggesting that effective risk stratification for Black women is now possible. This model may be especially valuable for risk stratification of young Black women, who are below the ages at which breast cancer screening is typically begun.

scholarly journals Breast Cancer Risks and Risk Prediction Models

Breast Care ◽  
2015 ◽  
Vol 10 (1) ◽  
pp. 7-12 ◽  
Author(s):  
Christoph Engel ◽  
Christine Fischer
Keyword(s):  
Breast Cancer ◽  
Ovarian Cancer ◽  
At Risk ◽  
Risk Prediction ◽  
Clinical Management ◽  
Prediction Models ◽  
Cancer Risks ◽  
Large Variability ◽  
Risk Prediction Models ◽  
Mutation Carriers

BRCA1/2 mutation carriers have a considerably increased risk to develop breast and ovarian cancer. The personalized clinical management of carriers and other at-risk individuals depends on precise knowledge of the cancer risks. In this report, we give an overview of the present literature on empirical cancer risks, and we describe risk prediction models that are currently used for individual risk assessment in clinical practice. Cancer risks show large variability between studies. Breast cancer risks are at 40-87% for BRCA1 mutation carriers and 18-88% for BRCA2 mutation carriers. For ovarian cancer, the risk estimates are in the range of 22-65% for BRCA1 and 10-35% for BRCA2. The contralateral breast cancer risk is high (10-year risk after first cancer 27% for BRCA1 and 19% for BRCA2). Risk prediction models have been proposed to provide more individualized risk prediction, using additional knowledge on family history, mode of inheritance of major genes, and other genetic and non-genetic risk factors. User-friendly software tools have been developed that serve as basis for decision-making in family counseling units. In conclusion, further assessment of cancer risks and model validation is needed, ideally based on prospective cohort studies. To obtain such data, clinical management of carriers and other at-risk individuals should always be accompanied by standardized scientific documentation.

scholarly journals A Review on Automatic Mammographic Density and Parenchymal Segmentation

2015 ◽  
Vol 2015 ◽  
pp. 1-31 ◽  
Author(s):  
Wenda He ◽  
Arne Juette ◽  
Erika R. E. Denton ◽  
Arnau Oliver ◽  
Robert Martí ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Risk Factors ◽  
Risk Assessment ◽  
Risk Prediction ◽  
Prediction Models ◽  
Prevention Measures ◽  
Clinical Environment ◽  
Tissue Segmentation ◽  
Risk Prediction Models ◽  
The Impact

Breast cancer is the most frequently diagnosed cancer in women. However, the exact cause(s) of breast cancer still remains unknown. Early detection, precise identification of women at risk, and application of appropriate disease prevention measures are by far the most effective way to tackle breast cancer. There are more than 70 common genetic susceptibility factors included in the current non-image-based risk prediction models (e.g., the Gail and the Tyrer-Cuzick models). Image-based risk factors, such as mammographic densities and parenchymal patterns, have been established as biomarkers but have not been fully incorporated in the risk prediction models used for risk stratification in screening and/or measuring responsiveness to preventive approaches. Within computer aided mammography, automatic mammographic tissue segmentation methods have been developed for estimation of breast tissue composition to facilitate mammographic risk assessment. This paper presents a comprehensive review of automatic mammographic tissue segmentation methodologies developed over the past two decades and the evidence for risk assessment/density classification using segmentation. The aim of this review is to analyse how engineering advances have progressed and the impact automatic mammographic tissue segmentation has in a clinical environment, as well as to understand the current research gaps with respect to the incorporation of image-based risk factors in non-image-based risk prediction models.

Risk prediction models for familial breast cancer

2006 ◽  
Vol 2 (2) ◽  
pp. 257-274 ◽  
Author(s):  
Antonis C Antoniou ◽  
Douglas F Easton
Keyword(s):  
Breast Cancer ◽  
Risk Prediction ◽  
Familial Breast Cancer ◽  
Prediction Models ◽  
Risk Prediction Models

scholarly journals Epidemic Models for Personalised COVID-19 Isolation and Exit Policies Using Clinical Risk Predictions

2020 ◽  
Author(s):  
Theodoros Evgeniou ◽  
Mathilde Fekom ◽  
Anton Ovchinnikov ◽  
Raphael Porcher ◽  
Camille Pouchol ◽  
...  
Keyword(s):  
Risk Prediction ◽  
Prediction Models ◽  
Epidemic Models ◽  
Sensitivity Analyses ◽  
Model Discrimination ◽  
Risk Models ◽  
Risk Prediction Models ◽  
Seir Model ◽  
Clinical Risk ◽  
Time Sensitivity

Background: In early May 2020, following social distancing measures due to COVID-19, governments consider relaxing lock-down. We combined individual clinical risk predictions with epidemic modelling to examine simulations of risk based differential isolation and exit policies. Methods: We extended a standard susceptible-exposed-infected-removed (SEIR) model to account for personalised predictions of severity, defined by the risk of an individual needing intensive care if infected, and simulated differential isolation policies using COVID-19 data and estimates in France as of early May 2020. We also performed sensitivity analyses. The framework may be used with other epidemic models, with other risk predictions, and for other epidemic outbreaks. Findings: Simulations indicated that, assuming everything else the same, an exit policy considering clinical risk predictions starting on May 11, as planned by the French government, could enable to immediately relax restrictions for an extra 10% (6 700 000 people) or more of the lowest-risk population, and consequently relax the restrictions on the remaining population significantly faster -- while abiding to the current ICU capacity. Similar exit policies without risk predictions would exceed the ICU capacity by a multiple. Sensitivity analyses showed that when the assumed percentage of severe patients among the population decreased, or the prediction model discrimination improved, or the ICU capacity increased, policies based on risk models had a greater impact on the results of epidemic simulations. At the same time, sensitivity analyses also showed that differential isolation policies require the higher risk individuals to comply with recommended restrictions. In general, our simulations demonstrated that risk prediction models could improve policy effectiveness, keeping everything else constant. Interpretation: Clinical risk prediction models can inform new personalised isolation and exit policies, which may lead to both safer and faster outcomes than what can be achieved without such prediction models.

Sign in / Sign up

Export Citation Format

Share Document